| To ensure you receive the Resident e-Bulletin, add
resebu...@nejm.org to your address book. | |||
| |||
|
| |||
| Teaching topics from the New England Journal of Medicine - Vol. 357, No. 19, November 8, 2007 |
|||
| NEJM Links: Current Table of Contents | Physician Jobs | Subscribe | Search NEJM |
| |||||||||||||||||||||||||||||||
| ||||||||||||
TEACHING TOPIC 1. Case of Ear Pain and Mental Status Changes CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL, Case 34-2007: A 77-Year-Old Man with Ear Pain, Difficulty Speaking, and Altered Mental Status, M.A. Samuels and Others, Extract | Full Text | PDF | PPT Slide Set A 77-year-old man was admitted to the hospital because of difficulty speaking and altered mental status. He had been well until the day before admission, when pain developed in the right side of his face and in his right ear. Several days earlier, he had fallen on the sidewalk and hit his head. On examination, he was lethargic with incomprehensible speech; dried blood was seen in his right ear canal. CT scanning of his head disclosed pneumocephalus and opacification of the right mastoid ear cells. Clinical Pearls The most common bacteria causing meningitis in adults are Streptococcus pneumoniae (about half of cases), Neisseria meningitidis (about one fifth of cases), Listeria monocytogenes (about one tenth of cases), and Haemophilus influenzae (about one tenth of cases). The otitic meningitis in this patient (whose ear infection may have caused bony erosion that led to a cerebrospinal fluid fistula) prompted the clinicians to consider more aggressive organisms such as Staphylococcus aureus, gram-negative organisms, and group A streptococcus. In fact, blood and cerebrospinal cultures became positive for group A streptococcus within a few hours. Infections with group A streptococcus are a rare cause of bacterial meningitis, accounting for 0.5 to 1.5% of community-acquired cases; the mortality rate (27%) is similar to that for pneumococcal meningitis (30%). Otitis media due to group A streptococcus is associated with high rates of local invasion, including tympanic perforation and mastoiditis, and this form of otitis media is the most important risk factor for group streptococcal meningitis among adult patients. Most patients with group A streptococcal meningitis do not have the clinical features of septic shock associated with invasive streptococcal disease, and the incidence of group A streptococcal meningitis has not increased, despite an increasing incidence of other forms of invasive disease. TEACHING TOPIC 2. Shock Therapy for Depression CLINICAL THERAPEUTICS, Electroconvulsive Therapy for Depression, S.H. Lisanby, Extract | Full Text | PDF | PPT Slide Set An 82-year-old woman with a history of recurrent unipolar major depression has had several episodes of major depression consisting of depressed mood, crying spells, loss of interest in usual activities, insomnia, loss of appetite and weight, difficulty concentrating, feelings of helplessness and hopelessness, and thoughts of suicide. She has tried various regimens of medications with no response. Is she a candidate for electroconvulsive therapy? Why or why not? Clinical Pearls The primary indications for electroconvulsive therapy (ECT) among patients with depression are lack of a response to or intolerance of antidepressant medications, a good response to previous ECT, and the need for a rapid and definitive response ( e.g., because of psychosis or a risk of suicide). ECT may be used in both unipolar and bipolar disorders. In the United States ECT treatments are usually administered three times weekly for approximately 6 to 12 treatments (two to four weeks), depending on the severity of the patient's symptoms and the rapidity of response. Figure 1. Standard Electrode Placements for Electroconvulsive Therapy. ECT for the treatment of depression and other psychiatric disorders involves the application of electric current via the scalp in order to induce seizure activity. ECT has been reported to result in prompt improvement in symptoms of depression in a majority of patients. The Consortium for Research in ECT (CORE) reported a 75% remission rate among 217 patients who completed a short course of ECT during an acute episode of depression; 65% entered remission by the fourth week of therapy. A systematic review of six trials indicated that the effect size for ECT was 0.91 (significantly more effective than sham ECT), and a review of 18 trials showed that the effect size of ECT was 0.80 (more effective than pharmacotherapy). (Lancet, 2003, UK ECT Review Group.) TEACHING TOPIC 3. Duration of Humoral Immunity ORIGINAL ARTICLE, Duration of Humoral Immunity to Common Viral and Vaccine Antigens, I.J. Amanna, N.E. Carlson, and M.K. Slifka, Abstract | Full Text | PDF | PPT Slide Set In this study, researchers performed a longitudinal analysis of antibody titers specific to viral antigens (vaccinia, measles, mumps, rubella, varicella–zoster virus, and Epstein–Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. The authors determined that antigen-specific antibody responses were measurably boosted through environmental exposure, infection, or vaccination (where it was applicable). The authors observed that antibodies to vaccinia, measles, and mumps were long-lived (estimated half-lives, 50 years), while antibodies against tetanus and diphtheria were shorter-lived (estimated half-lives, 11 and 19 years, respectively). For other results, see table below. Table 2. Duration of Antigen-Specific Serum Antibody Production. Clinical Pearls In contrast to acute viral infections, chronic and latent viral infections may either persist or be reactivated from latency, thereby "boosting" immune responses in the infected person. Unlike antibody responses to Epstein–Barr virus, antibody response to varicella–zoster virus showed frequent fluctuations in this study by Amanna and colleagues. Two subjects described an episode of shingles at or near the time of an observed spike in antibody responses to varicella–zoster virus, one subject may have been exposed to recently vaccinated children. Varicella–zoster virus induced the most short-lived antibody response of the viruses these authors examined. Humoral immunity to infection with Epstein–Barr virus showed no significant decrease and is likely to be maintained for life. In this study by Amanna and colleagues, in cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. The authors believe this suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity. |
| FEATURED JOB of the Week |
| |||||
| SPECIAL OFFER | ||
Physician's First Watch — A service from Journal Watch Physician's First Watch provides the latest medical news in a brief daily clinical update, delivered in your morning e-mail by 7:30 ET. Created by the physician-editors of Journal Watch and published by the New England Journal of Medicine, you can trust it to be first, fast, and absolutely FREE. Sign up now! |
| RESIDENT RESOURCES | ||
Find out what's "Most Popular" at NEJM Online View which articles are downloaded and e-mailed most frequently, what the press is covering, what articles bloggers are linking to, and what researchers are citing. See what the medical community feels are the most important developments. View what's Most Popular at NEJM Online now . |
Physician Employment Ads Attention Residents: Visit NEJM CareerCenter to search for physician jobs, apply online and set up e-mail alerts to have jobs automatically sent to you. Check out the Resource Center to learn about trends in compensation, employment contract do's and don'ts, and much more. |
| SEND US YOUR FEEDBACK | ||
E-mail the e-Bulletin editors with questions, comments or suggestions. | ||
Advertisement |
|
This document is meant as a guide to the NEJM; it is not intended to replace or reflect the entire contents of the Journal , but rather as a way to direct your attention to potential teaching topics contained in the contents of this week's NEJM. Subscribe to the Journal Thank you for subscribing to the New England Journal of Medicine's Resident e-Bulletin. The e-mail address for this subscription is: AUDIOL...@GMAIL.COM You are receiving this e-mail because you selected to receive the Resident e-Bulletin. If you wish to unsubscribe to the Resident e-Bulletin, please sign in to change your e-mail preferences. Please do not reply to this e-mail. This is an automated mailbox. If you have any questions or comments, please E-mail us. The New England Journal of Medicine 10 Shattuck Street, Boston, MA 02115-6094 Copyright © 2007 Massachusetts Medical Society. All rights reserved. |